361 Capital’s Xylem XYL Stock Holding History

361 Capital’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,966	Closed	-$80K	–	157
2016 Q1	$80K	Buy	+1,966	New	+$72.4K	0.6%	32

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

361 Capital's XYL Position: Q2 2016 in Review

361 Capital sold out of Xylem (XYL) in Q2 2016, closing a stake of 1,966 shares — an estimated $80K sold.

361 Capital first reported a position in XYL in Q1 2016 and held it in 1 quarter. The position peaked at $80K in Q1 2016. 523 funds tracked by Wall St. Rank hold XYL as of Q2 2016.

361 Capital reported no remaining Xylem position as of Q2 2016 after selling out during the quarter.
361 Capital sold 1,966 Xylem shares in Q2 2016, an estimated $80K.
361 Capital first reported a position in Xylem in Q1 2016 and held it in 1 quarter.
361 Capital's Xylem position peaked at $80K in Q1 2016.
523 funds tracked by Wall St. Rank held Xylem as of Q2 2016.

Based on 361 Capital's 13F filing for Q2 2016, filed 15 Aug 2016.